Fetal and neonatal therapies improve prognosis of congenital cytomegalovirus infection

(Kobe University) A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news